Top Markets
Coin of the day
Medicure Inc. Medicure Inc.

Medicure Inc.

MPH
Rank in Stocks #32234
Medicure Inc. is a biopharmaceutical firm focused on developing, researching,... Medicure Inc. is a biopharmaceutical firm focused on developing, researching, and commercializing therapeutic solutions for cardiovascular conditions across Canada and the United States. Its product portfolio includes AGGRASTAT, an injectable glycoprotein GP IIb/IIIa receptor antagonist prescribed for acute coronary syndromes, such as unstable angina and non-Q-wave myocardial infarction. The company also provides ZYPITAMAG, a medication used to manage primary hyperlipidemia and mixed dyslipidemia. Additionally, Medicure offers the ReDS system, a non-invasive medical device designed to measure lung fluid levels, aiding in the management of congestive heart failure. Another key offering is Sodium Nitroprusside injection, utilized for rapidly lowering blood pressure during hypertensive crises in both adult and pediatric patients, inducing controlled hypotension for surgical bleeding reduction, and treating acute congestive heart failure. These products are made available through both retail pharmacy networks and online platforms. Established in 1997, Medicure Inc. is headquartered in Winnipeg, Canada.
Share Price
$1.02
Last synced: 2026-08-17
Market Cap
$10.65M
Change (1 day)
2.21%
Change (1 year)
34.07%
Country
CA
Trade Medicure Inc. (MPH)

Category

Stock price history for Medicure Inc. (MPH)
Highest end of day price: $0.98 on 2026-08-01

Lowest end of day price: $0.57 on 2012-09-01
Stock price history of Medicure Inc. from 2012 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -6.88%
2025 36.71%
2024 -39.64%
2023 35.20%
2022 7.12%
2021 0.41%
2020 -79.23%
2019 -22.03%
2018 -18.25%
2017 -20.43%
2016 141.14%
2015 55.72%
2014 799.53%
2013 -49.29%
2012 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$161.79 25.18%
DE
$35.97 18.54%
JP
$220.05 32.86%
CH
$20.77 11.05%
IN